Entry |
|
Name |
EGF-EGFR-PI3K signaling pathway
|
Definition |
EGF -> EGFR -> PI3K -> PIP3 -> AKT -| BAD |
Expanded |
1950 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -| 572 |
Class |
|
Type |
Reference
|
Pathway |
|
Gene |
1950 | EGF; epidermal growth factor |
1956 | EGFR; epidermal growth factor receptor |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
207 | AKT1; AKT serine/threonine kinase 1 |
208 | AKT2; AKT serine/threonine kinase 2 |
10000 | AKT3; AKT serine/threonine kinase 3 |
572 | BAD; BCL2 associated agonist of cell death |
|
Metabolite |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
Reference |
|
Authors |
Cantley LC |
Title |
The phosphoinositide 3-kinase pathway. |
Journal |
|
Reference |
|
Authors |
Song G, Ouyang G, Bao S |
Title |
The activation of Akt/PKB signaling pathway and cell survival. |
Journal |
|
Reference |
|
Authors |
Hers I, Vincent EE, Tavare JM |
Title |
Akt signalling in health and disease. |
Journal |
|
Reference |
|
Authors |
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. |
Title |
Exploiting the PI3K/AKT pathway for cancer drug discovery. |
Journal |
|
LinkDB |
|